Magazine Article | August 9, 2017

Sanat Chattopadhyay — Shaping Merck's Manufacturing Future

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Sanat Chattopadhyay knows what it is like to face difficult tasks in the biopharma industry. When he was just 30 years old he was tapped to be the CEO of a small, wholly owned subsidiary of Hoechst Pharmaceuticals, India, engaged in manufacturing and selling of semisynthetic beta lactum antibiotics. The company wasn’t doing well, but he was expected to create something that he would be asked for over and over during his future career — a transformational turnaround.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.